CNP vs MNPR · P/E 26, rev $9.36B vs $431.4M cap
CenterPoint Energy Inc (CNP) versus Monopar Therapeutics Inc (MNPR) — a side-by-side from cached financials, not a winner call.
CenterPoint Energy Inc (CNP) is a utilities - regulated electric company listed on NYSE.
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
Latest reported CNP revenue for 2025-12-31 was $9.36B. Net income was $1.05B. Revenue was up 8.3% from 2024-12-31 to 2025-12-31. CNP currently screens at market cap $28.18B and trailing P/E 26.4.
Latest reported MNPR revenue for 2026-06-30 was $0. Net income was -$9.2M. MNPR currently screens at market cap $431.4M.
CNP currently screens at market cap $28.18B and trailing P/E 26.4. MNPR currently screens at market cap $431.4M.
Not investment advice. Open the CNP and MNPR stock pages for the full models.
Not investment advice.